
AbSci Announces Strategic Investment
AbSci Announces Strategic Investment Back to HomeVANCOUVER, WA, AbSci announced a strategic equity investment by Merck Global Health Innovation Fund. AbSci, a synthetic biology company, announced a strategic equity investment by Merck Global Health Innovation Fund (Merck GHI) and potential discovery collaborations with Merck Research Laboratories. AbSci is a leading synthetic biology company that translates ideas into drugs with a revolutionary platform technology that reinvents the biopharmaceutical drug discovery process.
Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.